
S-Nitrosothiol Analyzer For The Clinical Diagnosis Of Cardiovascular Disease MarkAward last edited on: 7/16/12
Sponsored Program
SBIRAwarding Agency
NIH : NHLBITotal Award Amount
$1,482,251Award Phase
2Solicitation Topic Code
-----Principal Investigator
Michael R PisanoCompany Information
Accord Biosciences Inc (AKA: Accord Biomaterials Inc)
Location: Multiple
Congr. District: 05
County: Lucas
Congr. District: 05
County: Lucas
Phase I
Contract Number: 1R43HL095181-01Start Date: 3/15/09 Completed: 8/31/09
Phase I year
2009Phase I Amount
$93,331Public Health Relevance:
The goal in this grant is to develop a novel electrochemical S-nitrosothiol (RSNO) sensor with enhanced limit of detection, and to determine the specifications to use this RSNO sensor as the detector to build a practical RSNO analyzer for clinical diagnostic applications. Currently there is no quick and convenient technique to measure endogenous RSNO concentrations reliably.
Public Health Relevance:
The goal in this grant is to develop a novel electrochemical S-nitrosothiol (RSNO) sensor with enhanced limit of detection, and to determine the specifications to use this RSNO sensor as the detector to build a practical RSNO analyzer for clinical diagnostic applications. Currently there is no quick and convenient technique to measure endogenous RSNO concentrations reliably.
Thesaurus Terms:
There Are No Thesaurus Terms On File For This Project.
Phase II
Contract Number: 2R44HL095181-02Start Date: 00/00/00 Completed: 00/00/00
Phase II year
2010(last award dollars: 2011)
Phase II Amount
$1,388,920Public Health Relevance:
The goal in this grant is to develop a novel electrochemical S-nitrosothiol (RSNO) sensor with enhanced limit of detection, and to determine the specifications to use this RSNO sensor as the detector to build a practical RSNO analyzer for clinical diagnostic applications, first for trial in pulmonary arterial hypertension (PAH). Currently there is no quick and convenient technique to measure endogenous RSNO concentrations reliably.
Public Health Relevance Statement:
The goal in this grant is to develop a novel electrochemical S-nitrosothiol (RSNO) sensor with enhanced limit of detection, and to determine the specifications to use this RSNO sensor as the detector to build a practical RSNO analyzer for clinical diagnostic applications, first for trial in pulmonary arterial hypertension (PAH). Currently there is no quick and convenient technique to measure endogenous RSNO concentrations reliably.
NIH Spending Category:
Bioengineering; Biotechnology; Cardiovascular; Clinical Research; Clinical Trials; Heart Disease
Project Terms:
Address; Affect; alpha-Cellulose; Assay; Bioassay; Bioavailability; bioavailability of drug; Biologic Assays; Biologic Availability; Biological Assay; Biological Availability; biomarker; Blood; Blood Glucose; Blood Plasma; Blood Sample; Blood specimen; Blood Sugar; Blood Vessels; BNP Gene Product; BNP-32; Brain natriuretic peptide; Brain Natriuretic Peptide-32; Calibration; Cardiac Catheterization Procedures; Cardiovascular Diseases; cardiovascular disorder; cardiovascular risk; cardiovascular risk factor; Catheterization, Cardiac; Cellulose; Cessation of life; Characteristics; Classification; Clinic; Clinical; clinical data repository; clinical data warehouse; clinical Diagnosis; Clinical Evaluation; clinical investigation; Clinical Research; clinical significance; Clinical Study; clinical test; Clinical Testing; Clinical Trials; Clinical Trials, Unspecified; clinically significant; Collection; comparison group; Data Banks; Data Bases; data repository; Databank, Electronic; Databanks; Database, Electronic; Databases; Death; design; designing; Detection; detector; Devices; Diagnosis; Diagnostic; Dialysis; Dialysis procedure; dialysis therapy; Disease; Disease Progression; disease/disorder; Disorder; drug/agent; Drugs; Dysfunction; Echocardiogram; Echocardiography; Electrodes; Endogenous Nitrate Vasodilator; endothelial cell derived relaxing factor; Endothelium-Derived Relaxing Factor; Equipment and supply inventories; Erythrocyte Volume, Packed; Ethics Committees, Research; Exhalation; Exhaling; Expiration, Respiratory; Family; Fingers; Functional disorder; glucose sensor; Goals; Grant; Hct; Heart; Heart Catheterization; Heart Catheterization Pocedure; heart sonography; Hematocrit; Hematocrit procedure; hemodynamics; Hemoglobin; HOSP; Hospitalization; improved; in vivo; Inflammation; INFLM; Insertion of catheter into heart chamber; Institutional Review Boards; Intravenous; Inventory; IRBs; language translation; Learning; Light; Lung; Marketing; Measurement; Measures; Medication; Membrane; membrane structure; Methods and Techniques; Methods, Other; Microfluidic; Microfluidics; Monitor; Mononitrogen Monoxide; Natriuretic factor, brain; Natriuretic Factor-32; Nesiritide; New York; Nitrates; Nitric Oxide; Nitric Oxide, Endothelium-Derived; Nitrites; Nitrogen Monoxide; Nitrogen oxide; Nitrogen Protoxide; novel; O element; O2 element; Oxygen; Packed Red-Cell Volume; Pathology; pathophysiology; Patients; Performance; Peripheral; Pharmaceutic Preparations; Pharmaceutical Preparations; Phase; Photoradiation; Physiologic; Physiologic Availability; Physiological; Physiopathology; Plasma; point of care; point-of-care diagnostics; Polyanhydroglucuronic Acid; Preparation; Pressure; pressure; Pressure- physical agent; Prevalence; Printing; Procedures; prototype; public health relevance; pulmonary; pulmonary arterial hypertension; quality assurance; Reagent; Registries; relational database; Reproducibility; Research; research clinical testing; Research Ethics Committees; Respiratory System, Lung; response; Reticuloendothelial System, Blood; Reticuloendothelial System, Serum, Plasma; Sampling; sensor; Serum, Plasma; Severities; sound measurement; Staging; Symptoms; System; System, LOINC Axis 4; Systematics; Techniques; Temperature; Testing; Therapeutic; tool; Translating; Translatings; transplant; Transplantation; Transthoracic Echocardiography; Treatment Failure; treatment response; Type-B Natriuretic Peptide; Validation; vascular; Veins; Venous; Walking